GlassScriptPhysician profile
Joseph D Rose
NPI 1245492925
$6,491.67
in general payments reported to CMS, 2019-2025
27 companies · $852 in 2025
The $852 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $205 · 2021: $4,105 · 2022: $266 · 2023: $357 · 2024: $254 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.85 |
| Education | $118.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,821.05 | 2021-2023 | Da Vinci Surgical System |
| Abbvie INC. | $574.27 | 2019-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Coopersurgical, INC. | $248.74 | 2019-2025 | Paragard T 380a |
| Pfizer INC. | $233.89 | 2019-2025 | |
| Therapeuticsmd, INC. | $196.81 | 2019-2022 | |
| Astellas Pharma US INC | $166.44 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $166.27 | 2022-2025 | |
| Biogen, INC. | $149.64 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $128.60 | 2025 | Novasure, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $86.77 | 2022-2025 | Phexxi, Solosec, Phexx |
| Amag Pharmaceuticals, INC. | $84.82 | 2019 | |
| Organon LLC | $78.30 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $64.92 | 2025 | Slynd |
| Dexcom, INC. | $64.73 | 2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $58.96 | 2024-2025 | Myfembree |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $53.20 | 2024 | |
| Exact Sciences Corporation | $48.39 | 2023-2024 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $42.21 | 2021 | |
| Myovant Sciences INC. | $38.62 | 2022 | |
| Minerva Surgical, INC | $38.23 | 2025 | |
| Allergan, INC. | $30.31 | 2019-2020 | |
| Lilly USA, LLC | $24.88 | 2025 | Zepbound, Mounjaro |
| Ascend Therapeutics US, LLC | $22.28 | 2019 | |
| Covidien LP | $20.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.41 | 2020 | |
| Merck Sharp & Dohme LLC | $16.02 | 2021 | |
| Daiichi Sankyo INC. | $15.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.